bioMérieux (OTCMKTS:BMXMF) Stock Passes Below Fifty Day Moving Average – Time to Sell?

by · The Cerbat Gem

bioMérieux S.A. (OTCMKTS:BMXMF – Get Free Report) passed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $113.87 and traded as low as $112.89. bioMérieux shares last traded at $112.89, with a volume of 9,557 shares traded.

Analyst Upgrades and Downgrades

Separately, UBS Group upgraded bioMérieux to a “strong-buy” rating in a research report on Thursday, August 22nd.

Check Out Our Latest Report on bioMérieux

bioMérieux Stock Performance

The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.19 and a current ratio of 2.03. The company has a 50-day simple moving average of $114.04 and a 200-day simple moving average of $106.95.

bioMérieux Company Profile

(Get Free Report)

bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.

Featured Stories